H.R. 9969 directs the Federal Trade Commission (FTC) to investigate and report to Congress on potentially unfair or deceptive practices in the advertising and marketing of preterm infant formula. The bill also mandates the FTC to issue regulations based on its findings to protect consumers.
The bill has been welcomed by consumer advocacy groups who argue that it is a necessary step to ensure the safety and integrity of marketing practices surrounding preterm infant formula, which is crucial for vulnerable populations. Supporters emphasize that increased regulation could lead to better consumer protection and more transparent marketing.
Critics have raised concerns that the bill may impose unnecessary regulations on manufacturers, potentially leading to increased costs for consumers and limiting access to essential products for preterm infants. Some argue that the FTC already has sufficient authority to address deceptive practices without additional legislation.
The donor data provided is entirely from individuals associated with Applied Materials, Inc., a company unrelated to the infant formula industry. There is no apparent conflict of interest between the donors and the bill concerning preterm infant formula advertising practices.
